TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07282587: Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Sponsor: Jazz Pharmaceuticals · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 90 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT07282587 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07282587 Rescue Dossier →